1. Introduction
===============

1.1. The disease and its epidemiology
-------------------------------------

Severe acute respiratory syndrome (SARS) is a highly contagious respiratory disease caused by a previously unknown coronavirus (CoV) named as SARS-CoV (SCoV) ([@bib45], [@bib71]). The major outbreak started from November 2002 as a rapid wave of epidemic from Guangdong Province of China and spread through 29 regions around the world ([@bib100]). The epidemic was effectively controlled under vigorous quarantine measures and no new case was reported after July 2003. Six months after its disappearance, SCoV re-emerged in December 2003 as four sporadic cases in Guangdong Province, causing no fatality or secondary transmission ([@bib101]). SCoV is probably one of the very few examples of zoonotic viral emergence 'caught-in-the-act' with adequate sequences sampled from different phases of the epidemic ([@bib13], [@bib98]), as well as highly relevant samples from its zoonotic origins ([@bib28], [@bib86], [@bib76]). Taking advantage of the wealth of these sequence data, the evolutionary behaviors of SCoV during the epidemic have been investigated extensively, e.g. chains of transmission, theoretic time of epidemic onset, rate of substitutions and mode of natural selection acting on the viral genome, *etc*. In the first half of this article, applications of phylogenetics for investigating the emergence and transmission of SCoV were reviewed.

1.2. The phylogenetic and zoonotic origins
------------------------------------------

Prior to the discovery of SCoV, members of the *Coronaviridae* family can be unambiguously classified into three phylogenetic groups. Although initial phylogenetic analyses did not confidently classify SCoV as a member of any of the three existing groups of CoV, futher analyses suggested SCoV might share an ancient and distant ancestry with Group 2 CoVs ([@bib85], [@bib25]). SCoVs were also isolated from small mammals such as civets in wet markets, suggesting these mammals may have been the direct zoonotic origin of SCoV ([@bib28]). Excitingly, wider animal surveys revealed unanticipated high levels of genetic diversity of CoV in bats ([@bib14]). A group of CoVs named as SARS-like CoVs (SLCoVs) which shares 88--92% nucleotide identity with SCoV, was also identified from bats ([@bib50], [@bib56]). These findings lead to the hypothesis that bats are the natural reservoir of SCoV and other members of the *Coronaviridae* family ([@bib92], [@bib96]). The biological and evolutionary aspects related to the conjectured inter-species transmission of SLCoV from its natural reservoir (i.e. bats) to the intermediate host (i.e. civets), and finally to human, have been the center of discussion ([@bib83]). In the second half of this article, the phylogenetic origins of SCoV, as well as the diversity of CoVs in its zoonotic sources and the phylogenetic aspects of the speculated inter-species transmission events, were reviewed.

2. Dissecting the epidemiology of SARS outbreaks from a phylogenetic perspective
================================================================================

2.1. Super-spreading 'caught-in-the-act'
----------------------------------------

Epidemiology of the SARS epidemic has been well-documented and one of its most intriguing characteristics is the concept of "super-spreading events" (SSE) ([@bib65]), which contributed significantly to the rapid spread of the disease locally and globally ([@bib59], [@bib81], [@bib10], [@bib119]). In mid-November 2002, the epidemic started as a series of seemingly independent cases and followed by the first documented SSE in Hospital HSZ-2 in Guangdong at the end of January 2003 ([@bib119]). By then, an infected nephrologist traveled from Guangdong to Hong Kong and initiated another SSE in Hotel M at the end of February 2003, leading to the worldwide transmission of SARS and subsequent outbreaks in Hong Kong ([@bib79], [@bib27]). The epidemic has been divided into three phases ([Fig. 1](#fig1){ref-type="fig"} ) based on the occurrence of the above two mentioned SSEs ([@bib13]). The early phase refers to the period prior to the SSE in Hospital HSZ-2 while the late phase refers to the period after to the SSE in Hotel M. The middle phase refers to the period between these two SSEs.Fig. 1A phylogeny of *spike* gene nucleotide sequences from SCoV isolated from humans, civets and raccoon dogs. This phylogeny was modified and adopted from [@bib46]. Sequences from humans, civets, raccoon dogs and bats were indicated with symbols ■, ○, ▴ and ♦, respectively. The tree was constructed using ML method, with confidences of topology summarized from 5000 trees sampled from ML and NJ bootstrap replicates and BMCMC samples. Only confidence values of major clusters were shown (ML/NJ/BMCMC, in the parenthesis). The human epidemic cluster (2002--2003) was divided into late, early and middle phases according to a previous study ([@bib13]). Accession numbers of the sequences are shown within round brackets after their strain names (in bold). The distance unit was substitutions/site. Rp3 isolated from bats (♦) was used as an out-group to root the tree, and the genetic distance of its branch is not shown.

Phylogenetic analyses enabled researchers to better understand the transmission chains and trace the sources of viral epidemics, which provide important information for making public health policy. Broadly speaking, phylogenies of SCoV sequences generally agreed with the documented contact histories, and additionally provided evidence to support some uncorroborated epidemiological speculations ([@bib117]). Phylogenies reconstructed by Neighbor Joining (NJ) ([@bib13], [@bib27]), Maximum Likelihood (ML) ([@bib114], [@bib90]) and Bayesian methods ([@bib91]) consistently distinguished the late phase strains as a monophyletic cluster, which included the index patient of the SSE in Hotel M and the primary cases in Vietnam, Singapore and Canada ([@bib27]), supporting the viewpoint that the SARS outbreaks later in Hong Kong, as well as those in other parts of the world, were largely, if not completely, originated from a common source. In fact, analyses of the S gene sequences suggested multiple strains might have been independently introduced into Hong Kong from Guangdong before the SSE in Hotel M, although none of these strains contributed substantially to the subsequent outbreaks ([@bib94], [@bib27]). On the other hand, the strains from early and middle phases are relatively more diverse and appeared as multiple distinct clusters on the phylogenies ([@bib13], [@bib86], [@bib99]), agreeing with the epidemiological investigations that SCoVs have been circulating in Guangdong and caused seemingly independent outbreaks prior to the SSE in Hotel M ([@bib119]). This observation fits the model put forward by [@bib2] and implies the possible occurrence of multiple zoonotic transmissions of phylogenetically distinct, but yet similar, SCoVs to human in the early phase of the epidemic.

2.2. Tracing the source of local outbreaks in the late phase epidemic
---------------------------------------------------------------------

The epidemiology of some local outbreaks in the late phase was also investigated using phylogenetics. Firstly, two major subsequent outbreaks in Hong Kong, the Amoy Gardens outbreak ([@bib69]) and the Hospital P outbreak ([@bib93]), were phylogenetically demonstrated to be directly linked to the SSE in Hotel M ([@bib11], [@bib27]). Secondly, phylogenies suggested the Taiwan outbreaks were likely to be derived from multiple sources ([@bib49], [@bib84]), including the Amoy Gardens outbreak ([@bib12], [@bib48]) and the SSE in Hotel M ([@bib110]). Thirdly, the Singapore outbreak was traced back to two separate initial introductions, but both were directly linked to the SSE in Hotel M ([@bib79], [@bib95]), which later led to several other subsequent outbreaks within Singapore ([@bib10]) and a case in Germany ([@bib62]). Lastly, in Beijing, although the first case was reported approximately a week after the SSE in Hotel M ([@bib5]), phylogenetic analyses suggested not all the cases in Beijing were related to the SSE in Hotel M and some of the cases were likely originated from the Guangdong prior SSE ([@bib64], [@bib117]).

2.3. Estimating the theoretical onset of the epidemic
-----------------------------------------------------

Robust estimations on the theoretical onset of a viral epidemic provide evidence to testify the hypotheses on viral origins, e.g. AIDS pandemic ([@bib43], [@bib52], [@bib51], [@bib107]). Under the assumption of adequate sampling, the theoretical onset of a viral epidemic can be inferred as the time of the most recent common ancestor (tMRCA) of all sampled sequences. tMRCA can be estimated using a range of phylogenetic methods ([@bib18]), but all methods are primarily based on the assumption of molecular clocks of different extents ([@bib74]). It is noted that this tMRCA should theoretically be older than the earliest documented case, given the fact that there must be a window period between the emergence and recognition of the epidemic and the length of this window period is often a significant epidemiological interest ([@bib89], [@bib107]).

In the case of SCoV, linear regression methods which correlate divergence with sampling dates were commonly used to estimate the tMRCA in the early studies. Based on simple linear regression, [@bib112] estimated the tMRCA of all human SCoVs at around December 2002, with the 95% credible interval (CI) from September 2002 to January 2003, which is comparable to a later similar study, with the same estimate at around November 2002 (95% CI from June 2002 to December 2002) ([@bib13]). Later, [@bib118] adopted three strategies to minimize possible errors and inferred the oldest bound of this tMRCA as early as spring 2002. A least square method, evaluated using Monte Carlo simulations, has also been applied to estimate the onset of the epidemic as August to September 2002 ([@bib66]). While all the above studies relied on the assumption of a constant evolutionary rate over all lineages, i.e. a strict molecular clock ([@bib74]), enforcing a molecular clock to non-clocklike datasets could lead to biased estimations ([@bib111]). More recently, [@bib80] applied a ML method to testify the clocklike behavior of a dataset of ten taxa and placed this tMRCA between September and November of 2002.

Despite the differences in methods and datasets, the above studies generally inferred the oldest bound of the onset of the epidemic at around mid-late 2002. The earliest documented case of SARS was identified on 16th November 2002 ([@bib119]), which is remarkably close to the oldest bounds of its theoretical onset when compared with other well-known viral epidemics ([@bib89], [@bib107]). This finding suggests the SCoV has been quickly recognized after its emergence in human, partially reflecting the explosive mode of transmission in early phase of the epidemic.

After the discovery of SCoV in civets and sporadic re-emergence of SCoV in December 2003, these SCoV strains have been incorporated into datasets for estimation of their tMCRA ([@bib86], [@bib96], [@bib35]). This tMRCA represents the upper limit of the time (i.e. oldest bound) of the inter-species transmission of SCoV from civets to human, which is phylogenetically different from the tMRCA of all human SCoVs discussed above and should theoretically be older. The estimated time of this inter-species transmission event will be discussed later in Section [4](#sec1){ref-type="sec"}.

2.4. Sporadic re-emergence in December 2003
-------------------------------------------

In December 2003, four seemingly independent cases of SCoV infection were reported ([@bib60], [@bib101]). All the patients have direct or indirect contact history with wild animals ([@bib86], [@bib98]). Phylogenetic analyses of human SCoVs from these sporadic cases and civet SCoVs collected from the same period formed a monophyletic group distinct from the SCoVs of the 2002--2003 epidemic ([Fig. 1](#fig1){ref-type="fig"}), suggesting these sporadic cases were likely caused by inter-species transmissions that were independent from the previous outbreak ([@bib86], [@bib46]). These epidemiological and phylogenetic findings provided convincing evidence for direct transmission of SCoV from civets to human (discussed later in Section [4](#sec1){ref-type="sec"}).

In summary, the above findings demonstrated the vital roles of phylogenetics in understanding the emergence and transmission of SCoV in such a short-lasting but sweeping epidemic. The adequacy of early phase sampling and the relatively short duration of the SARS epidemic make it an excellent textbook example on how phylogenetic analyses can be used as an auxiliary tool in combination with classical epidemiological investigations to study the emergence of a viral epidemic.

3. Controversies over the phylogenetic origins of SCoV
======================================================

3.1. The ancient history of a novel CoV
---------------------------------------

Which of the existing groups of CoV is phylogenetically closest to SCoV? This question has been under the spotlight of most discussions because the answer might help to trace the zoonotic origin of SCoV that is fundamentally important to public health. Prior to the availability of its complete genome sequences, initial phylogenetic analyses of a fragment of ORF1 suggested that SCoV may represent a novel group that is independent to the other three existing groups ([@bib17], [@bib45]). Similar conclusions were reached based on phylogenetic analyses on multiple viral proteins after the complete genome sequences were available ([@bib67], [@bib78], [@bib113]). Based on the observation that SCoV appears to be genetically equidistant to other known CoV groups, [@bib34] concluded that SCoV is neither a recent host-range mutant of a known CoV nor a recent recombinant between known CoVs, but it probably evolved separately from an ancestor of the known CoVs in an unidentified host for a remarkably long period of time before its emergence in human.

Although the above argument was generally well-received, two follow-up questions were then raised. The first question is: If SCoV represents a lineage that anciently diverged from an ancestor of the existing CoVs, would this ancestor belong to one of the existing CoV groups? It later led to the concept of "early split-off from Group 2 CoV" for describing the phylogenetic origin of SCoV ([@bib85]). The second question is: Is SCoV an "ancient-recombinant" (if not a "recent-recombinant") between the ancestors of any existing CoV groups? Due to relatively high divergence between SCoV and other CoVs ([@bib78]) as well as the lack of a robust out-group ([@bib32]), the conclusions derived from various recombination analyses were yet intricate and inconsistent ([@bib25]). A number of reasons were then proposed to explain the observed phylogenetic incongruence might not truly reflect the recombinant origin of SCoV ([@bib32]). The following sessions summarized the findings from numerous studies regarding the controversial phylogenetic origins of SCoV.

3.2. SCoV as an early-split off from Group 2 CoV: arguments and contentions
---------------------------------------------------------------------------

Following the initial analyses ([@bib67], [@bib78], [@bib113]), the phylogenetic position of SCoV have been vigorously reevaluated with various approaches that were mainly different in their choices of genome regions ([@bib21], [@bib120], [@bib42]) and rooting strategies ([@bib85], [@bib24], [@bib61]). Inspired by the positional conservation of cysteine residues between the S1 region of SCoV and Group 2 CoVs, [@bib85] constructed an unrooted NJ phylogeny based on the amino acid sequences of S1 region and concluded SCoV is "closely related" to Group 2 CoVs ([@bib21]). In two later studies, concatenated amino acid alignments of multiple viral proteins were used to construct unrooted phylogenies using various methods and the results consistently demonstrated the monophyletic relationship between SCoV and Group 2 CoVs ([@bib120], [@bib42]). In addition to these unrooted phylogenies, rooted phylogenies based on ORF1 alignments reached similar conclusions that SCoV and Group 2 CoV shared the last common ancestor ([@bib85], [@bib24], [@bib61]). However, depends on the choices of out-groups, the rooting positions in these studies were inconsistent, which might be related to the possibly compromised accuracy of alignment if the out-groups are too diverged to be aligned ([@bib32]).

Nonetheless, the consensus of above findings is that SCoV could be classified as a "distant" member of Group 2 CoVs ([@bib25]). This conclusion was reached primarily based on the robustness of the monophyletic relationship between SCoV and Group 2 CoVs. However, considering the actual genetic distance between SCoV and Group 2 CoVs, which is comparable to the inter-group distance among the three CoV groups, the biological significance of classifying SCoV as a distant member of Group 2 CoV is relatively low at best. We believe classification of a novel CoV should not be merely based on the branching orders of phylogenies and quantitative measurement of genetic distance should also be taken into account.

On the other hand, reconstructing the evolutionary relationships between highly divergent taxa has been proven as a difficult phylogenetic task ([@bib72]). In particular, the observed branching order of the deep nodes in the highly divergent CoV phylogenies may not reflect their true evolutionary history, due to the possible influences of the long-branch attraction and rate variation among lineages ([@bib26], [@bib32]). In fact, Holmes and Rambaut reevaluated the tree topologies depicting the three possible phylogenetic positions of SCoV using Kishino-Hasegawa test, which is not biased by rate variations, and that demonstrated the topology with the best likelihood is not necessarily significantly better than the other two topologies, even the deep nodes were well-supported by quartet puzzling support values ([@bib32]). This finding indicated careful interpretations are needed before reaching a firm conclusion from the branching order of deep phylogenies.

Until recently, the addition of several newly discovered CoV lineages to the phylogeny broke up some of those long branches ([@bib32]), which tends to distribute the convergent and parallel mutations more evenly across the tree and hence reduce the problem of long-branch attraction ([@bib31]). In [Fig. 2](#fig2){ref-type="fig"} , the closer phylogenetic relationship between SCoV and Group 2 CoVs suggested from the previous studies is also supported in this relatively well-sampled phylogeny. To this end, the question of whether it is appropriate to classify SCoV as a distant member of Group 2 CoVs seems to be a taxonomic problem more than a virological one, since SCoV and Group 2 CoVs are so divergent that they are likely to possess a substantial number of unique biological characteristics, e.g. host ranges and receptor usages ([@bib29], [@bib55]). With the recent discoveries of novel CoV lineages, the classification of coronaviruses has to be revised systematically in both biological and phylogenetic context.Fig. 2A phylogeny of all known CoVs (*n* = 40). The phylogeny was constructed based on the amino acid sequences of the RNA-dependent RNA Polymerase region (length = 163 a.a.). The phylogeny was constructed using BEAST ([@bib20]) under a uncorrelated lognormally relaxed clock model ([@bib19]). The number at the nodes indicates the Bayesian posterior probability support (as percentages) summarized from trees sampled at every 1000th step of a BMCMC chain of 10,000,000 steps where values lower than 80% were not shown. The mean substitution rate was fixed at 1.0 and the branch length was expressed in units of substitutions per site. *FIPV*, Feline infectious peritonitis virus ([AY994055](ncbi-n:AY994055)); *CFBGDDM9503*, Chinese ferret badger CoV 2003 ([EU769560](ncbi-n:EU769560)); *PRCV*, Porcine respiratory CoV ([DQ811787](ncbi-n:DQ811787)); *TGEV*, Transmissible gastroenteritis virus ([NC_002306](ncbi-n:NC_002306)); *PEDV*, Porcine epidemic diahrrea virus ([NC_003436](ncbi-n:NC_003436)); *BtCoV5122005*, Bat CoV 512-2005 ([NC_009657](ncbi-n:NC_009657)); *BatCoVHKU6*, Bat CoV HKU6 (DQ249224); *BtCoV1A*, Bat CoV 1A ([NC_010437](ncbi-n:NC_010437)); *BtCoV1B*, Bat CoV 1B ([NC_010436](ncbi-n:NC_010436)); *BatCoVHKU8*, Bat CoV HKU8 ([NC_010438](ncbi-n:NC_010438)); *HCoV229E*, Human CoV 229E ([NC_002645](ncbi-n:NC_002645)); *HCoVNL63*, Human CoV NL63 ([NC_005831](ncbi-n:NC_005831)); *BatCoVHKU2*, Bat CoV HKU2 ([EF203064](ncbi-n:EF203064)); *HCoVOC43*, Human CoV OC43 ([NC_005147](ncbi-n:NC_005147)); *BCoV*, Bovine CoV ([NC_003045](ncbi-n:NC_003045)); *AntelopeCoV*, Sable antelope CoV ([EF424621](ncbi-n:EF424621)); *GiCoV*, Giraffe CoV ([EF424622](ncbi-n:EF424622)); *PHEV*, Porcine hemagglutinating encephalomyelitis virus ([NC_007732](ncbi-n:NC_007732)); *SDAV*, Rat sialodacryoadenitis CoV ([AF124990](ncbi-n:AF124990)); *MHV*, Mouse hepatitis virus ([NC_006852](ncbi-n:NC_006852)); *HCoVHKU1*, Human CoV HKU1 ([NC_006577](ncbi-n:NC_006577)); *BatCoVHKU9*, Bat CoV HKU9 ([NC_009021](ncbi-n:NC_009021)); *SCoV* ([NC_004718](ncbi-n:NC_004718)); *Rp3*, Bat SLCoV ([NC_009693](ncbi-n:NC_009693)); *BatSCoVHKU3*, Bat SLCoV HKU3 ([NC_009694](ncbi-n:NC_009694)); *Rm1*, Bat SLCoV ([NC_009696](ncbi-n:NC_009696)); *Rf1*, Bat SLCoV ([NC_009695](ncbi-n:NC_009695)); *BtCoV1332005*, Bat CoV-133-2005 ([NC_008315](ncbi-n:NC_008315)); *BatCoVHKU4*, Bat CoV HKU4 ([NC_009019](ncbi-n:NC_009019)); *BatCoVHKU5*, Bat CoV HKU5 ([NC_009020](ncbi-n:NC_009020)); *IBV*, Infectious bronchitis virus ([NC_001451](ncbi-n:NC_001451)); *IBVpeafowl*, peafowl CoV ([AY641576](ncbi-n:AY641576)); *IBVpartridge*, partridge CoV ([AY646283](ncbi-n:AY646283)); *TCoV*, Turkey CoV ([NC_010800](ncbi-n:NC_010800)); *SW1*, Beluga whale CoV ([NC_010646](ncbi-n:NC_010646)); *BuCoVHKU11*, Bulbul CoV ([NC_011548](ncbi-n:NC_011548)); *ThCoVHKU12*, Thrush CoV ([NC_011549](ncbi-n:NC_011549)); *MuCoVHKU13*, Munia CoV ([NC_011550](ncbi-n:NC_011550)); *ALCGXF23006*, Asian leopard cat CoV 2006 ([EF584908](ncbi-n:EF584908)); *CFBGXF24706*, Chinese ferret badger CoV 2006 ([EF584911](ncbi-n:EF584911)).

3.3. Phylogenetic incongruence and ancient recombination: facts and cautions
----------------------------------------------------------------------------

Phylogenetic incongruence, which is often justified by incompatible tree topologies for different genome regions ([@bib33]), has been widely used as an indicator for homologous recombination among viral genomes ([@bib73]). Several studies demonstrated phylogenetic incongruence within the genome of SCoV based on a wide range of methods ([@bib77], [@bib87], [@bib88], [@bib116]). Despite the statistical significance of the phylogenetic incongruence observed in these studies, we could not conclude a consensus pattern of recombination since their findings were generally inconsistent. As an example, the potential recombination events within S gene proposed by [@bib116] were different from those proposed by [@bib88], and were undetectable from the study of [@bib77]. In fact, the considerable divergence between SCoV and the existing CoV groups has already excluded the possibility that SCoV is a recent recombinant from the existing CoV groups. Alternatively speaking, if recombination events had occurred, they have to be the ancient ones ([@bib6]), i.e. both the parents and daughter could have been evolved considerably after the recombination events. A simulation study demonstrated the accuracy for detecting these ancient recombination events can be substantially diminished if they were significantly obscured by the subsequent post-recombination substitutions ([@bib9]). Therefore, the intricacy of the findings on the phylogenetic incongruence within the genome of SCoV may be a reflection of the varying sensitivity of the detection methods on the ancient and obscured recombination events, if any.

To further investigate the reported phylogenetic incongruence within the genome of SCoV, Rambaut and Holmes re-evaluated the study of [@bib88] and suggested the patterns cited as evidence for recombination are more probably caused by a variation in substitution rate among lineages ([@bib32]). In addition, the author also stated the effect of the long-branch attraction on the branching order of deep phylogenies may also be a source of artifact, although unproven. Moreover, even if recombination did not occurred, given the stochastic nature of evolution, the authors would expect to observe phylogenetic incongruence among small genome fragments of a set of divergent taxa like SCoV and other CoVs. Therefore, the observed phylogenetic incongruence among the highly divergent genomes of CoV and its possible indication on ancient recombination events should be interpreted with extra cautions. Up to this point, the current phylogenetic evidence supporting the recombinant history of SCoV is weak at best ([@bib32]).

Putting aside the intricate phylogenetic evidence, the presence of stem-loop II motif (S2m) in the genome of SCoV have also been taken as an indication for recombination ([@bib67]). S2m is a conserved RNA motif present in the genomes of several members of *Astroviridae*, *Coronaviridae*, and *Picornaviridae* family ([@bib39]) while SCoV and Group 3 CoVs are the only members of the *Coronaviridae* that posse the motif. Assuming the motif in SCoV and Group 3 CoV were not acquired independently, the explanation of the co-presence of S2m should be either, (1) SCoV and Group 3 CoVs share the same ancestry, or (2) SCoV have acquired the motif from Group 3 CoVs through recombination (or vice versa). Currently, the phylogenetic data does not provide a better support for any of the above scenarios but a wider survey for the presence of S2m in other unknown CoV lineages will certainly provide insights to the ancient evolutionary history of the *Coronaviridae* family.

4. Zoonotic origins of SCoV {#sec1}
===========================

4.1. Civets as the immediate source of SARS epidemics
-----------------------------------------------------

Since the early SARS cases in Guangdong seems to be related to restaurant workers handling wild mammals, [@bib28] surveyed the wild animals in a local market and isolated CoVs from Himalayan palm civets, which share 99.8% genome sequence identity to the SCoVs in human. Initial phylogenetic analyses suggested SCoVs from human and civets formed two distinct clades ([@bib28]), but the SCoVs from civets are phylogenetically closer to the SCoVs of the early-phase epidemic than to those in the late-phase epidemic ([@bib41]). These findings strongly suggest civets were the immediate sources of the SCoVs leading to the earliest SARS cases in Guangdong. The role of civets as the immediate zoonotic source of the SARS epidemic was further revealed during the sporadic re-emergence of SCoV in December 2003 ([@bib98]), based on the observation that the SCoVs isolated from civets and those patients of the same period formed a monophyletic cluster ([@bib86], [@bib46]). These findings suggested that the emergence of SCoV in human is likely to be resulted from direct transmissions of SCoVs from civets. In addition, phylogenetic analyses demonstrated that the SCoVs from the 2002--2003 epidemic and the 2003--2004 re-emergence are phylogenetically distinct, suggesting the inter-species transmission events from civets to human in the two outbreaks might be independent ([@bib86], [@bib98]).

However, a large-scale survey of SCoVs of civets in market in China suggested the lack of widespread infections in civets ([@bib41]). In addition, the genetic diversity of civet SCoVs was relatively limited and was comparable to that of human SCoVs ([@bib86], [@bib46]). These findings suggested civets might not be the natural reservoir of SCoV and it only acquired SCoVs shortly before the emergence of SCoV in human. Based on phylogenetic analyses using dynamic homology, [@bib37] speculated that civets might also acquired SCoV from other species, possibly human, even after the emergence of SCoV in 2002. An experimental evidence suggesting civets may not be the natural reservoir of SCoV is the observed symptoms in civets experimentally infected with SCoV ([@bib108]), based on the fact that the natural reservoir hosts usually do not display severe signs of infection ([@bib36]). The above observations lead to the speculation of another natural reservoir host, which harbors a diverse group of SCoV-related CoVs and transmitted SCoV to civets prior to the emergence of SCoV in human.

4.2. Horseshoe bats as the natural reservoir of SCoV and SLCoV
--------------------------------------------------------------

As a result of extensive searches for the natural reservoir of SCoV, two groups of researchers independently identified a diverse group of CoVs from various species of horseshoe bats (*Rhinolophus* spp.). These CoVs shared 87--92% genome nucleotide identity with SCoVs and formed a distinct monophyletic cluster with SCoVs, therefore they were named SARS-like CoV ([@bib50], [@bib56]). The close evolutionary relationship between SCoV and SLCoV is also supported by the presence of the S2m motif in their 3′UTR ([@bib92], [@bib83]). Based on the phylogenetic analyses of the four characterized full genomes of SLCoV in horseshoe bats, the remarkably high genetic diversity of SLCoVs strongly suggested horseshoe bats are the natural reservoir of SCoV and SLCoV ([@bib76]). This concept is further supported by the relatively high prevalence of SLCoV in *R. sinicus* ([@bib50]) and the geographically widespread infections of SLCoVs in bats from distinct locations in China ([@bib56]). The current hypothesis is that civets might have acquired SLCoVs from horseshoe bats and transferred to human, which is consistent with the observation that the 29-nt deletion in ORF8 are retained in bat SLCoVs, civet SCoVs and early phase human SCoV ([@bib50]).

4.3. The missing link between SCoVs in civets and currently sampled SLCoVs in bats
----------------------------------------------------------------------------------

Although the hypothesis of horseshoe bats as the natural reservoir for SLCoV and SCoV is relatively sensible, how bats SLCoV were transmitted to civets is still unexplained. If civets acquired SLCoV from bats shortly prior to its emergence in human as proposed, this bat SLCoV strain should be genetically very similar to the SCoVs sampled from civets. However, based on the relatively distant phylogenetic relationship between SCoVs and SLCoVs, none of the currently sampled SLCoVs in bats is the descendant of the direct ancestor of SCoVs in human and civet ([@bib35]). In particular, Li and coworkers pointed out that substantial genetic changes in the S protein of the currently sampled SLCoV are likely to be necessary for the virus to infect civets or human ([@bib57]). Therefore, the direct ancestor of SCoVs in human and civets remains elusive.

More recently, [@bib35] demonstrated significant phylogenetic discordances among different genome regions of SLCoV strain Rp3 and speculated its potentially recombinant origin. Phylogenetic analysis of the parental regions of Rp3 genome suggested the presence of an uncharacterized bat SLCoV lineage (i.e. HB-SLCoV in [Fig. 3](#fig3){ref-type="fig"} ) that is phylogenetically closer to SCoVs than any of the currently sampled bat SLCoVs. Based on the relatively high genetic diversity among the currently sampled SLCoVs in bats, the existence of a phylogenetically distinct lineage of SLCoV not yet sampled is highly possible. Thus, the authors speculated that the direct ancestor of SCoVs was as a descendant derived from this not yet sampled lineage, which crossed from a horseshoe bat species to civets ([@bib35]).Fig. 3A time-scaled phylogeny of SCoV and SLCoV. This phylogeny was modified and adopted from [@bib35]. The phylogeny was summarized from all MCMC phylogenies of the *Orf1* data set analyzed under a Bayesian relaxed clock model. Height of the nodes was represented by the median of its estimates. The window period between the cross-species event and the onset of SARS epidemic was indicated as a dotted line. In the taxa labels, *H*, *C* and *B* represent host of human, civets and bats, respectively.

4.4. Estimated time of the inter-species transmission events and their implications
-----------------------------------------------------------------------------------

Determining the time of inter-species transmission events might help us to comprehend the viral zoonosis of the virus from an evolutionary standpoint. The oldest bound of the inter-species transmission of SCoV from civets to human is theoretically correspondent to the tMRCA of all human and civet SCoVs. Firstly, [@bib86] estimated the synonymous substitution rate of SCoVs using linear regression and placed this tMRCA to be around early December 2002 without providing CI. In a later study, [@bib96] investigated this tMRCA by applying a Bayesian relaxed clock model ([@bib19]) to a phylogeny of all representatives from the CoV family and estimated it at around 1999 with 95% posterior bounds of 13 years (i.e. 1990--2003). More recently, [@bib35] reconsidered this tMRCA using various clock models and estimated it at around September 2002 with 95% CIs between January and December of 2002. This tMRCA is very close to the observed first case of SARS (16th November 2002) as well as the estimated onset of the epidemic (as discussed earlier), suggesting SCoVs might have crossed from civets to human just months before the outbreak, supporting the view that civets are the immediate zoonotic source of SCoVs in human. It also implies the civet SCoVs might have adapted quickly, or alternatively speaking, a 'by-pass' host with only minimal adaptation is needed, to establish a sustainable chain of transmission in human.

On the other hand, the time of the speculated inter-species transmission of SLCoV from bats to civets has also been investigated. In the study described earlier ([@bib96]), the oldest bound of the time of this event was first estimated at a mean of 1986 with a 38-year credible interval (i.e. 1964--2002). Later, [@bib35] employed the concept of estimating the period between time of divergence (tDIV) and tMCRA proposed by [@bib47], and speculated this inter-species transmission event might have happened with a median of 4.08 years before onset of the epidemic (credible intervals of 1.45--8.84 years) ([Fig. 3](#fig3){ref-type="fig"}). The above two estimates are not contradictory since the later estimate falls within the credible intervals of the former estimate but with an improved precision. Based on this relatively short window period between the inter-species transmission event and onset of the epidemic, [@bib35] speculated that civets might have acquired the ancestor of SCoV from the host species of SLCoV strain Rp3 directly and the involvement of other intermediate species may be unlikely. Therefore, authors suggested more focused surveillance on the host species of SLCoV strain Rp3 may shed light on the zoonotic origin of the direct ancestor of SCoV in civets.

4.5. Adaptive mutations potentially relevant to inter-species transmission
--------------------------------------------------------------------------

The host specificity of CoVs is mainly determined by the binding between the spike (S) protein and its cellular receptors ([@bib29]). Angiotensin I-converting enzyme 2 (ACE2) is a functional receptor for SCoVs in both human ([@bib55]) and civets ([@bib58]), and was demonstrated to interact with the receptor binding domain (RBD) in the S1 subunit of the S protein ([@bib102]). Based on the observed mutations within the RBD in strains from different epidemic phases and hosts, [@bib58] demonstrated that binding of S1 subunit to human and civet ACE2 can be significantly altered by mutating only two residues on the RBD (residue 479 and 487), suggesting these two residues may contribute to the adaptation of SCoV from civet to human. Later, this viewpoint was further supported by the location of these two residues at the binding interface between RBD and ACE2 in crystal structures ([@bib54], [@bib53]).

As observed in other examples of viral host shifts ([@bib70]), the molecular determinants for host specificity, e.g. RBD residues related to adaptation to human in the case of SCoV, are likely to be subjected to an elevated level of selection pressure during the acquisition of a new host. The ratio of non-synonymous (dN) to synonymous substitution rate (dS), i.e. ω, which is widely used as a measure for selection pressure ([@bib109]), has been employed in several studies to detect positive selection on viral genes of SCoV and SLCoV. Firstly, the ω values of structural genes were found to be higher than that of the non-structural region, suggesting the structural proteins might have been under a stronger selection pressure ([@bib118], [@bib86]). Moreover, the ω value of S gene in the strains from early phase is significantly larger than that of those from middle and late phases ([@bib13]). The above findings provided preliminary phylogenetic evidence for the potential role of S protein in adaptation of SCoV from civets to human.

Additionally, lineage-specific ω in the S gene phylogeny (*n*  = 11) was estimated using a codon-based genetic algorithm ([@bib44]), and a significantly higher ω value was observed along the lineage leading to the human cluster ([@bib96]). More recently, [@bib91] comprehensively analyzed a larger dataset (*n*  = 59) using a ML branch-site codon model ([@bib115]), aimed at comparing the ω values of lineages of various epidemic phases or hosts (i.e. foreground) versus the rest of the phylogeny (i.e. background). The authors concluded that the 2002 early and middle phase human lineages and the 2003 sporadic-re-emergence human-civet lineages are under positive selection. Despite the differences in methodologies and datasets, both studies demonstrated phylogenetic evidence for positive selection along lineages relevant to the civets-to-human inter-species transmission on the S gene phylogeny.

On the other hand, positively selected residues on S protein have been identified in a number of similar studies, primarily by applying ML codon models to similar datasets but with different epidemic groupings ([@bib115], [@bib114], [@bib82]). Although the residues identified from these studies are not completely overlapping, probably due to the differences in taxa groupings, these sites are mainly located in the S1 subunit and residue 479 is consistently detected to be under positive selection, supporting its speculated roles in adaptation for new hosts ([@bib86]). It should be noted that positively selected residues were not identified in the S genes from neither the late epidemic phase ([@bib114]) nor the SLCoV in bats ([@bib115]). The mode of selection relevant to the inter-species transmission from bats to civets has not been investigated systematically, primarily due to the lack of bat SLCoV S gene sequences that are phylogenetically close enough for robust analysis.

5. The continuing story of CoV diversity
========================================

5.1. The expanding diversity and widening host range
----------------------------------------------------

As a result of the extensive efforts in searching for the zoonotic origins of SCoV, our knowledge on the host range and diversity of CoVs has been expanded rapidly. For example, in the last couple of years, the number of avian species detected to harbor Group 3 CoVs has been doubled ([@bib7]). Furthermore, in addition to the two newly discovered human CoVs in the existing Group 1 and 2, i.e. NL63 ([@bib23]) and HKU1 ([@bib103]), respectively, a number of divergent CoVs have been identified from Asian Leopard Cats and Chinese Ferret Badgers ([@bib16]), wild birds ([@bib105]) and a beluga whale ([@bib68]). These findings largely expanded the known diversity of CoVs and the long-established classification of the *Coronaviridae* family as three distinct groups needs to be revised systematically. On the other hand, a number of diverse CoVs belonging to Group 1 and 2 have been identified from a range of bat species ([@bib106]). The surprisingly high diversity of bat CoVs rationally leads to the hypothesis that bats are the natural reservoir of all CoVs ([@bib92]). According to a time-scaled phylogeny of representative CoVs from all groups, [@bib96] concluded that bats are likely to be the host of the ancestor for all presently known CoV lineages. Furthermore, based on the results of their Bayesian coalescent analyses, the authors speculated a diverse group of CoVs may be endemic in various bat species, with repeated introduction to other animals and occasional establishment of new lineages in other species ([@bib96]). In fact, other than the speculated inter-species transmission of CoVs from bats to other animal species, hosts shifts of bat CoVs between different *Rhinolophus* spp. were also proposed based on the incongruence between the phylogenies of CoVs and their host *Rhinolophus* spp. ([@bib14]).

Additionally, inter-species transmissions of CoVs between other non-bat species were also proposed. The first animal-human zoonotic pair of CoVs being detailedly analyzed was Bovine CoV and Human CoV-OC43 ([@bib97]). Based on a combination of molecular clock analyses, the authors estimated the tMRCA of these two CoVs at around 1890 and speculated an inter-species transmission event from Bovine CoV to human might have occurred around this period ([@bib97]). Moreover, a number of CoVs are documented to infect multiple closely related host species, e.g. bovine CoVs has been isolated from captive wild ruminants ([@bib1]); closely related Group 3 CoVs have been isolated from various avian species ([@bib8], [@bib40], [@bib63]). These findings implied the relatively promiscuous nature of the host specificity of CoVs, which was best demonstrated by the evidence of inter-species transmission of highly similar if not identical SCoVs between two distantly related species, i.e. human and civets ([@bib98]).

5.2. How much did recombination contribute to the diversity of CoV?
-------------------------------------------------------------------

Last but not least, the relatively high rate of homologous recombination has been speculated to facilitate the inter-species transmissions of CoVs ([@bib3], [@bib4]). Despite the lack of relevant examples to support this hypothesis, naturally occurring recombination between CoV strains of the same species ([@bib38]), as well as between strains of different CoV species, have been documented ([@bib30], [@bib35], [@bib15]), suggesting the generation of CoV diversity through recombination has been happening in the field. In fact, the two recently discovered human CoVs were proposed to have a recombinant history based on the observed phylogenetic incongruence between different genome regions ([@bib104], [@bib75]). As discussed earlier, due to the relatively high divergence between different groups of CoV, cautions have to be taken to interpret these phylogenetic incongruences as evidence for ancient recombination events ([@bib32], [@bib9]). In summary, the current data only suggests the occurrence of recombination between closely related CoV strains, but provides no direct evidence to support a role of recombination in the emergence of novel CoVs in novel host species, e.g. emergence of SCoV in human.

6. The lesson learnt and an alarm for next zoonosis
===================================================

The SARS epidemic in 2003 offers a solid lesson on the application of phylogenetics in understanding the epidemiology of a newly established epidemic, as well as the evolutionary basis of a zoonotic viral emergence. Phylogenetics has played an indispensable role in the prompt identification of the transmission chains and its zoonotic origins, which provided important clues for the policy-making in public health, e.g. customs and border control, quarantine measures, culling of civets and the continuous search for the viral natural reservoir. These valuable experiences should help the community to better prepare for the next zoonotic viral epidemic.

More importantly, while most of the attentions have been focused on preparing for the known potential pandemics like avian influenza ([@bib22]), the unanticipated strike of SARS epidemic alarmed public health officials and researchers for the neglected possibility of deadly viral emergence from an unexpected origin. For many years, CoVs have long been regarded as relatively "mild" viruses with broad but yet restricted host ranges. However, according to our current understanding to the diversity and evolution of CoVs ([@bib96]), at least five divergent species of CoV are known to have zoonotic transmission into the human population and this cross species event will be likely to continue, and the zoonosis of SCoV was just the consequence of one of these inter-species transmission events. Although the prevention of zoonosis from an unexpected origin seems to be impractical, sufficiently flexible and stringent surveillance strategies provide us an opportunity to anticipate the disease in a population and prevent its further spreading by implementing appropriate control measures. The sporadic re-emergence of SCoV in the early 2004 illustrated the importance of stringent surveillance in preventing the further spread of a zoonotic virus in the early phase. One step further, the surveillance strategies must be adopted in a way that we could learn more about the diversity of potentially zoonotic viruses in their reservoirs. With CoV as an example, given the relatively promiscuous nature of its host specificity as discussed above, extensive and regular surveillance of known CoVs in pets and agricultural animals, which are in close contact with human, should be set up. Well-established knowledge on the diversity of potentially zoonotic viruses certainly accelerates the identification of its animal origin once it emerges in human. Last but not least, although the immediate zoonotic source of SCoV seems to be eliminated by culling of civets in Mainland China, the uncertainties about the diversity of SLCoV in bats still pose threat on the recurrence SCoV ([@bib35]). Therefore, we emphasize the importance of continuous surveillance on the genetic diversity of SLCoV in bats.
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